MH
WST icon

Mark Hillman’s West Pharmaceutical WST Stock Holding History

Mark Hillman’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
7,106
-1,800
-20% -$550K 1.85% 23
2026
Q1 		$2.23M Hold
8,906
– – 1.55% 34
2025
Q4 		$2.45M Sell
8,906
-1,367
-13% -$374K 1.54% 36
2025
Q3 		$2.69M Buy
+10,273
New +$2.5M 1.57% 36

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mark Hillman's WST Position: Q2 2026 in Review

Mark Hillman reduced its West Pharmaceutical (WST) stake by 20% in Q2 2026, selling an estimated $550K and leaving 7,106 shares worth $2.55M. The position accounts for 1.85% of the portfolio, ranked #23.

Mark Hillman first reported a position in WST in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.69M in Q3 2025. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Mark Hillman held 7,106 shares of West Pharmaceutical worth $2.55M as of Q2 2026.
  • Mark Hillman sold 1,800 West Pharmaceutical shares in Q2 2026, an estimated $550K.
  • West Pharmaceutical made up 1.85% of Mark Hillman's portfolio in Q2 2026, its #23 holding.
  • Mark Hillman first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Mark Hillman's West Pharmaceutical position peaked at $2.69M in Q3 2025.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hillman Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.